Advanced search
Search Results: 23 results for keyword "Imexpharm".
Imexpharm welcomes shareholders, analysts and potential investors at AGM
26-04-2024 16:37
Imexpharm Corporation (Imexpharm), a pioneering leader in Vietnam’s pharmaceutical industry, held its AGM at the Hilton Saigon Hotel on April 26.
Outlook for pharmaceutical stocks in 2024
22-04-2024 08:00
At a macro level in which there is still complexity, the pharmaceutical industry is expected to continue witnessing positive business results in 2024.
Imexpharm set growth record in 2023
02-04-2024 08:00
Imexpharm Corporation (Imexpharm or IMP.VN), a pioneer in Vietnam’s pharmaceutical industry, announced its business results on March 27, for the fiscal year ending December 31, 2023.
Imexpharm joins Vietnam's campaign to plant one billion trees
22-03-2024 14:04
Imexpharm Pharmaceutical JSC (IMP) teamed up with Nha Trang People's Committee to plant 500 trees along Ring Road 2 on March 18.
Imexpharm forges partnership with Genuone Sciences
27-02-2024 11:16
On February 23, Imexpharm JSC (IMP) officially announced the signing of a strategic cooperation agreement with Genuone Sciences Inc., one of the leading pharmaceutical companies from South Korea.
Imexpharm opens new representative office in Ho Chi Minh City
21-02-2024 14:45
Imexpharm has opened a new office to grasp fresh opportunities for growth after a period of in-depth investment in modern production technologies.
Domestic pharmaceutical products anticipate 2024 boost
23-01-2024 10:15
2023 witnessed many fluctuations in the economy, with various industrial fields witnessing negative growth, but the pharmaceutical industry remains growing thanks to the breakthroughs of leading pharmaceutical companies.
Imexpharm clinches top honours in corporate annual reporting
28-12-2023 14:18
Imexpharm, outstripping its 2023 financial targets, underscores its ascent with top honours in corporate governance, affirming its stature in Vietnam's pharmaceutical sector.
SK Investment Vina III to hold 65 per cent of Imexpharm
28-12-2023 11:20
SK Investment Vina III Pte. Ltd (SK Vina III), a subsidiary of South Korea’s third-largest conglomerate SK Group, aims to hold a 65 per cent stake in Imexpharm Pharmaceutical JSC (IMP).
Imexpharm honoured as top 5 company with best working environment in Vietnam
30-11-2023 14:05
Imexpharm Pharmaceutical JSC has been named in the top 5 companies with the best working environment in Vietnam for pharmaceuticals, medical devices, and healthcare companies in the medium-sized enterprise category.
Imexpharm raises its status with EU-GMP-standard factories
25-11-2023 17:38
Operating the largest pharmaceutical production lines that meet European standards (EU-GMP) in Vietnam, Imexpharm has great potential to become a leading pharmaceutical enterprise. These advantages are also shown through the company's impressive business results.
Imexpharm making inroads in achieving sustainable efficiency
01-03-2022 18:00
After four decades of development, Imexpharm Corporation has reaffirmed its position as a market leader in Vietnam’s pharmaceutical industry by investing in sustainable technology and human resources.
Imexpharm Corporation reports dropping revenue during social distancing
23-09-2021 08:00
In August, Imexpharm Corporation recognised a decrease of 12 per cent in revenue and 14 per cent in profit due to social distancing.
SK Investment Vina raises ownership to 29.2 per cent in Imexpharm
15-06-2021 20:43
SK Investment Vina III Pte., Ltd. has spent over VND34.5 billion ($1.5 million) to acquire 3.4 million shares of Imexpharm Pharmaceutical JSC to raise its ownership at the firm to 29.22 per cent.
Targets being tweaked by prepared pharma
09-06-2021 20:53
There remains caution over interruption in the ingredient supply chain in Vietnam’s lucrative pharmaceutical industry, but new strategies to intensify growth potential ahead will ensure pharma groups maintain their profitability moving forward.
Mobile Version